Related references
Note: Only part of the references are listed.Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
Saghi Nooraei et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Development of a Virus-Like Particle-Based Anti-HER2 Breast Cancer Vaccine
He Hu et al.
CANCERS (2021)
Construction of Ribonuclease-Decorated Artificial Virus-like Capsid by Peptide Self-assembly
Kazunori Matsuura et al.
JOURNAL OF ORGANIC CHEMISTRY (2020)
Fully Synthetic Invariant NKT Cell-Dependent Self-Adjuvanting Antitumor Vaccines Eliciting Potent Immune Response in Mice
Pu-Guang Chen et al.
MOLECULAR PHARMACEUTICS (2020)
Protein Supramolecular Structures: From Self-Assembly to Nanovaccine Design
Ximena Zottig et al.
NANOMATERIALS (2020)
Immunological Evaluation of Co-Assembling a Lipidated Peptide Antigen and Lipophilic Adjuvants: Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidates
Taku Aiga et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Enveloped artificial viral capsids self-assembled from anionic β-annulus peptide and cationic lipid bilayer
Hiroto Furukawa et al.
CHEMICAL COMMUNICATIONS (2020)
Construction of Artificial Viral Capsids Encapsulating Short DNAs via Disulfide Bonds and Controlled Release of DNAs by Reduction
Yoko Nakamura et al.
CHEMISTRY LETTERS (2019)
Sublingual administration of liposomes enclosing alpha-galactosylceramide as an effective adjuvant of allergen immunotherapy in a murine model of allergic rhinitis
Satoshi Suzuki et al.
ALLERGOLOGY INTERNATIONAL (2019)
Artificial Viral Capsid Dressed Up with Human Serum Albumin
Kazunori Matsuura et al.
BIOCONJUGATE CHEMISTRY (2019)
Liposomal Antitumor Vaccines Targeting Mucin 1 Elicit a Lipid-Dependent Immunodominant Response
Jing-Jing Du et al.
CHEMISTRY-AN ASIAN JOURNAL (2019)
Cell cytotoxicity, immunostimulatory and antitumor effects of lipid content of liposomal delivery platforms in cancer immunotherapies. A comprehensive in-vivo and in-vitro study
Amin Reza Nikpoor et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Syntheses and Functional Studies of Self-Adjuvanting Anti-HER2 Cancer Vaccines
Qi Feng et al.
CHEMISTRY-AN ASIAN JOURNAL (2019)
Syntheses and Immunological Evaluation of Self-Adjuvanting Clustered N-Acetyl and N-Propionyl Sialyl-Tn Combined with a T-helper Cell Epitope as Antitumor Vaccine Candidates
Tsung-Che Chang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Biomaterials for vaccine-based cancer immunotherapy
Rui Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Development of the iLiNP Device: Fine Tuning the Lipid Nanoparticle Size within 10 nm for Drug Delivery
Niko Kimura et al.
ACS OMEGA (2018)
Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
Mona O. Mohsen et al.
VACCINES (2018)
Peptide Delivery Systems for Cancer Vaccines
Xuedan He et al.
ADVANCED THERAPEUTICS (2018)
Lymph node targeting strategies to improve vaccination efficacy
Hao Jiang et al.
JOURNAL OF CONTROLLED RELEASE (2017)
DNA-modified artificial viral capsids self-assembled from DNA-conjugated -annulus peptide
Yoko Nakamura et al.
JOURNAL OF PEPTIDE SCIENCE (2017)
Self-assembled artificial viral capsids bearing coiled-coils at the surface
Seiya Fujita et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2017)
Interactions of conjugate vaccines and co-administered vaccines
H. Findlow et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Encapsulation of CdTe Quantum Dots into Synthetic Viral Capsids
Seiya Fujita et al.
CHEMISTRY LETTERS (2016)
Virus-based nanoparticles as platform technologies for modern vaccines
Karin L. Lee et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2016)
Synthesis of a TLR4 Agonist-Carbohydrate Antigen Conjugate As A Self-Adjuvanting Cancer Vaccine
Jordan D. Lewicky et al.
CHEMISTRYSELECT (2016)
Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide
Pamela Thompson et al.
CHEMICAL COMMUNICATIONS (2015)
NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity
Regan J. Anderson et al.
CHEMICAL SCIENCE (2015)
Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice
Rui Tada et al.
PLOS ONE (2015)
Self-assembled artificial viral capsid decorated with gold nanoparticles
Kazunori Matsuura et al.
POLYMER JOURNAL (2015)
A semisynthetic carbohydrate-lipid vaccine that protects against S-pneumoniae in mice
Marco Cavallari et al.
NATURE CHEMICAL BIOLOGY (2014)
Fully Synthetic Self-Adjuvanting Thioether-Conjugated GlycopeptideLipopeptide Antitumor Vaccines for the Induction of Complement-Dependent Cytotoxicity against Tumor Cells
Hui Cai et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Guest-binding behavior of peptide nanocapsules self-assembled from viral peptide fragments
Kazunori Matsuura et al.
POLYMER JOURNAL (2013)
Protein carriers of conjugate vaccines Characteristics, development, and clinical trials
Michael E. Pichichero
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Carbohydrate-Monophosphoryl Lipid A Conjugates Are Fully Synthetic Self-Adjuvanting Cancer Vaccines Eliciting Robust Immune Responses in the Mouse
Qianli Wang et al.
ACS CHEMICAL BIOLOGY (2012)
Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients From US Military Cancer Institute Clinical Trials Group Study I-01 and I-02
Elizabeth A. Mittendorf et al.
CANCER (2012)
a Totally Synthetic, Self-Assembling, Adjuvant-Free MUC1 Glycopeptide Vaccine for Cancer Therapy
Zhi-Hua Huang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
Vani Lakshminarayanan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Fully Synthetic Vaccines Consisting of Tumor-Associated MUC1 Glycopeptides and a Lipopeptide Ligand of the Toll-like Receptor 2
Anton Kaiser et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Self-Assembled Synthetic Viral Capsids from a 24-mer Viral Peptide Fragment
Kazunori Matsuura et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Results of the First Phase 1 Clinical Trial of the HER-2/neu Peptide (GP2) Vaccine in Disease-Free Breast Cancer Patients
Mark G. Carmichael et al.
CANCER (2010)
Anti-HER2 vaccines: new prospects for breast cancer therapy
Maha Zohra Ladjemi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Vaccine Adjuvants: Putting Innate Immunity to Work
Robert L. Coffman et al.
IMMUNITY (2010)
Increasing the Antigenicity of Synthetic Tumor-Associated Carbohydrate Antigens by Targeting Toll-Like Receptors
Sampat Ingale et al.
CHEMBIOCHEM (2009)
Eleven years of Inflexal® V-a virosomal adjuvanted influenza vaccine
Christian Herzog et al.
VACCINE (2009)
Results of the first phase I clinical trial of the novel Ii-key hybrid preventive HER-2/neu peptide (AE37) vaccine
Jarrod P. Holmes et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Robust immune responses elicited by a fully synthetic three-component vaccine
Sampat Ingale et al.
NATURE CHEMICAL BIOLOGY (2007)
Share Paper
